Ace investor Vijay Kedia boosted his smallcap exposure in Q4 by acquiring 4.53% in Mahamaya Lifesciences and 1.88% in SPML Infra. Kedia, known for spotting multibaggers early, added these picks as both firms show improving momentum, aligning with his long-standing preference for SME and niche growth stories.